Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Post-transplant complications including neoplastic disorders such as carcinoma and lymphomas, related primarily to chronic immunosuppression, are well recognised.1 Post-transplant lymphoproliferative disorders (PTLDs) are a group of lymphoid or plasmacytic proliferations that develop as a consequence of immunosuppression after receipt of a solid organ, bone marrow or stem cell allograft and for which there is no other known explanation.2 3
A young person underwent a successful renal transplant for end-stage renal failure in 1995 in a different hospital. His post-transplant medications included ciclosporin (stopped in 1997), azathioprine and prednisolone. This patient presented to us 14 years later with intermittent painless haematuria. CT scan revealed a large bulky, heterogeneous mass measuring 8×9×5.6 cm in the posteroinferior wall of the bladder …
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.